<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02591953</url>
  </required_header>
  <id_info>
    <org_study_id>15101504</org_study_id>
    <nct_id>NCT02591953</nct_id>
  </id_info>
  <brief_title>Prospective Clinical Analysis of Ultrasound-guided Biceps Corticosteroid Injections</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rush University Medical Center</source>
  <brief_summary>
    <textblock>
      Using randomization, prospectively determine superiority of either ultrasound-guided or
      landmark-guided biceps corticosteroid injections with regard to various clinical variables.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are diagnosed with biceps tendinitis in the outpatient clinic. After diagnosis, all
      the patients that meet inclusion/exclusion criteria will be offered to enroll in the study.
      Study will be described to the patient with regard to protocol and consent. All questions
      regarding the study will be answered, and it will be explicitly described that the study
      involvement will not change clinical care. It will be explained that investigators expect a
      follow up appointment at minimum at three weeks and three months. There may be further follow
      up requested up to 1 year from enrollment.

      After collection of informed consent, the patient will be randomized to either
      ultrasound-guided or landmark-guided injection. The patient will complete clinical scores at
      the initial visit prior to the injection. After injection, the patient will have follow up
      scheduled for three weeks and three months. To ensure patient blinding, an ultrasound will be
      placed on the patient for both groups, but only active imaging with be performed for the
      ultrasound-guided patient group. For clinician blinding, a different clinician than the
      injecting clinician will perform the follow up examinations. The patient is instructed to not
      seek additional injections or physical therapy during the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ASES Shoulder Score</measure>
    <time_frame>1 year</time_frame>
    <description>Orthopedic Pain and Function Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Speed's Test</measure>
    <time_frame>1 year</time_frame>
    <description>Physical Exam maneuver measured as positive or negative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tenderness over Bicepital Groove</measure>
    <time_frame>1 year</time_frame>
    <description>Physical exam maneuver measured as yes or no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simple Shoulder Test</measure>
    <time_frame>1 year</time_frame>
    <description>12 question assessment of shoulder function with yes or no answers</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Biceps Tendonitis</condition>
  <condition>Injection</condition>
  <arm_group>
    <arm_group_label>Ultrasound-guided Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection performed with ultrasound-guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Landmark-guided Injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection performed at point of maximal tenderness along biceps tendon</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound-guidance</intervention_name>
    <description>Using ultrasound-guidance to perform a corticosteroid injection</description>
    <arm_group_label>Ultrasound-guided Injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Landmark-guidance</intervention_name>
    <description>Using landmark-guidance to perform a corticosteroid injection</description>
    <arm_group_label>Landmark-guided Injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone</intervention_name>
    <description>Corticosteroid used in injection (40 mg)</description>
    <arm_group_label>Ultrasound-guided Injection</arm_group_label>
    <arm_group_label>Landmark-guided Injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 1%</intervention_name>
    <description>Anesthesic used in injection</description>
    <arm_group_label>Ultrasound-guided Injection</arm_group_label>
    <arm_group_label>Landmark-guided Injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pain at intertubercular groove

          -  Anterior humeral pain

          -  Positive Speed's Test

          -  Bicep's tendinitis is primary diagnosis for patient

          -  Patient agrees to follow up and consent

        Exclusion Criteria:

          -  Prior biceps surgery or injections

          -  Prior SLAP or labral repair

          -  Concomitant shoulder arthroplasty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jeremy A Alland, MD</last_name>
    <phone>3124322452</phone>
    <email>jeremy_a_alland@rush.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jae Kim, MA</last_name>
    <phone>3124322452</phone>
    <email>romeo.research@rushortho.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Midwest Orthopeadics at Rush</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy A Alland, MD</last_name>
      <phone>312-432-2434</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.aaos.org/news/aaosnow/jan15/clinical5.asp</url>
    <description>AAOS Statement of Musculoskeletal Ultrasound</description>
  </link>
  <link>
    <url>http://journals.lww.com/cjsportsmed/Fulltext/2015/01000/American_Medical_Society_for_Sports_Medicine.2.aspx</url>
    <description>AMSSM Statement of Interventional Musculoskeletal Ultrasound</description>
  </link>
  <reference>
    <citation>Hashiuchi T, Sakurai G, Morimoto M, Komei T, Takakura Y, Tanaka Y. Accuracy of the biceps tendon sheath injection: ultrasound-guided or unguided injection? A randomized controlled trial. J Shoulder Elbow Surg. 2011 Oct;20(7):1069-73. doi: 10.1016/j.jse.2011.04.004. Epub 2011 Jul 22.</citation>
    <PMID>21782470</PMID>
  </reference>
  <reference>
    <citation>Zhang J, Ebraheim N, Lause GE. Ultrasound-guided injection for the biceps brachii tendinitis: results and experience. Ultrasound Med Biol. 2011 May;37(5):729-33. doi: 10.1016/j.ultrasmedbio.2011.02.014. Epub 2011 Mar 31.</citation>
    <PMID>21458143</PMID>
  </reference>
  <reference>
    <citation>Ucuncu F, Capkin E, Karkucak M, Ozden G, Cakirbay H, Tosun M, Guler M. A comparison of the effectiveness of landmark-guided injections and ultrasonography guided injections for shoulder pain. Clin J Pain. 2009 Nov-Dec;25(9):786-9. doi: 10.1097/AJP.0b013e3181acb0e4.</citation>
    <PMID>19851159</PMID>
  </reference>
  <reference>
    <citation>Naredo E, Cabero F, Beneyto P, Cruz A, Mond√©jar B, Uson J, Palop MJ, Crespo M. A randomized comparative study of short term response to blind injection versus sonographic-guided injection of local corticosteroids in patients with painful shoulder. J Rheumatol. 2004 Feb;31(2):308-14.</citation>
    <PMID>14760802</PMID>
  </reference>
  <reference>
    <citation>Aly AR, Rajasekaran S, Ashworth N. Ultrasound-guided shoulder girdle injections are more accurate and more effective than landmark-guided injections: a systematic review and meta-analysis. Br J Sports Med. 2015 Aug;49(16):1042-9. doi: 10.1136/bjsports-2014-093573. Epub 2014 Nov 17. Review.</citation>
    <PMID>25403682</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2015</study_first_submitted>
  <study_first_submitted_qc>October 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2015</study_first_posted>
  <last_update_submitted>November 20, 2016</last_update_submitted>
  <last_update_submitted_qc>November 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rush University Medical Center</investigator_affiliation>
    <investigator_full_name>Jeremy A Alland</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

